维也纳医学院招聘两名博士后

NK CELL -BASED ANTI -CANCER IMMUNOTHERAPIES
2 post-doctoral fellows 11 PhD students

Within a newly formed ITN we are searching for 2 postdoctoral fellows* and 11 PhD students interested in the native immune response of natural killer cells to herpes viruses and tumors and the development of leukemia therapies. Candidates should have a solid basis in molecular medicine, cell biology, immunology, gene technology and/or bioinformatics:

- Erhard Hofer , Medical University of Vienna*
- James di Santo , Institute Pasteur, Paris
- Ofer Mandelboim , Hebrew University, Jerusalem
- Miguel Lopez-Botet , Universitat Pompeu Fabra, Barcelona
- John Trowsdale , University of Cambridge
- Thomas Schlitt , King´s College London
- Amit Nathwani/Stephan Beck , University College London
- Ulrike Koehl , Medical University of Hannover
- Volker Huppert , Miltenyi Biotec, Bergisch Gladbach
- Dirk Groenewegen , Glycostem Therapeutics, Nijmegen
- Eugene Zhukovsky , Affimed Therapeutics AG, Heidelberg*

The training program pursued will include research training in the individual laboratories with regular exchange between the laboratories and 6 Summer/Winter Schools including seminars, workshops and specific training courses in advanced bioinformatics at KCL and EBI , priority rights at the European Patent Academy and the management of biotech business at Vienna University of Economics. Fellowships will run for 2 (post-docs) or 3 years (PhD students) and start between October 2012 and September 2013.

Applications including CV, publication list (if available), and addresses of two referees should be sent to Prof. E. Hofer, Medical University of Vienna, under the E-mail address:
sandra.schulz@meduniwien.ac.at

Recruitment will start in October, so early application will be an advantage. Candidates are required to undertake trans-national mobility, i.e. at the time of recruitment they must not have resided in the country of their host institution for more than 12 months within the last 3 years.